Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRTG is expected to report earnings to fall 88.30% to -21 cents per share on August 15
Q1'24
Est.
$-0.22
Q4'23
Missed
by $1.61
Q3'23
Missed
by $0.02
Q2'23
Missed
by $0.95
Q1'23
Missed
by $5.07
The last earnings report on February 28 showed earnings per share of -187 cents, missing the estimate of -27 cents. With 4.78K shares outstanding, the current market capitalization sits at 7.32M.